Koers NH TherAguix SAS

Aandelen

Beurs gesloten - Euronext Paris Andere beurzen 02:34:17 22-10-2021			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,01 ^EUR	-.--%		-.--%	-.--%

Duur

Periode

Stijl

NH TherAguix SAS : announces the publication of promising preclinical results of AGuIX® in combination with targeted radioligand therapies (TRT)	19/12
NH TherAguix SAS : appoints Vincent Carrère as Chief Executive Officer	12-09-23
NH TherAguix SAS : announces communications to be presented at the AAPM meeting by Harvard Medical Schools collaborators	21-07-23
NH TherAguix SAS : announces the arrival of Aurélien Meyzaud as Head of Intellectual Property and Business Intelligence	13-01-23
NH TherAguix SAS : announces the thesis defense of Dr. Paul Rocchi as the first NHT-funded PhD student	09-11-22

Managers	Titel	Leeftijd	Van
Vincent Carrère CEO	Chief Executive Officer	-	-
Géraldine Le Duc FOU	Founder	-	11-12-15
Caroline Cayre DFI	Director of Finance/CFO	-	01-08-19

Besturend	Titel	Leeftijd	Van
Philippe Archinard BRD	Director/Board Member	63	22-02-19
Marc Le Bozec BRD	Director/Board Member	-	22-02-19
Hervé Eloi Dominique Brailly CHM	Chairman	62	22-02-19